Protagonist Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTGX and other ETFs, options, and stocks.

About PTGX

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943.

CEO

Dinesh V. Patel

CEODinesh V. Patel

Employees

126

Employees126

Headquarters

Newark, California

HeadquartersNewark, California

Founded

2006

Founded2006

Employees

126

Employees126

PTGX Key Statistics

Market cap

3.42B

Market cap3.42B

Price-Earnings ratio

69.67

Price-Earnings ratio69.67

Dividend yield

—

Dividend yield—

Average volume

897.74K

Average volume897.74K

High today

$55.40

High today$55.40

Low today

$53.13

Low today$53.13

Open price

$53.24

Open price$53.24

Volume

758.05K

Volume758.05K

52 Week high

$60.60

52 Week high$60.60

52 Week low

$32.50

52 Week low$32.50

Analyst ratings

92%

of 12 ratings

Buy

91.7%

Hold

8.3%

Sell

People also own

Based on the portfolios of people who own PTGX. This list is generated using Robinhood data, and it’s not a recommendation.